메뉴 건너뛰기
Irish Journal of Medical Science
Volumn 181, Issue 4, 2012, Pages 569-570
Cardiomyopathy of Friedreich's Ataxia (FRDA)
Author keywords

[No Author keywords available]
Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;
EID: 84867848300     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-012-0808-7     Document Type: Letter
Times cited : (13)
References (10)
  • 1
    • 82955190595 scopus 로고    scopus 로고
    • Friedreich's Ataxia: A review from a cardiology perspective
    • 21822977 10.1007/s11845-011-0744-y 1:STN:280:DC%2BC3MbgsFaruw%3D%3D
    • Bourke T (2011) Keane D (2011) Friedreich's Ataxia: a review from a cardiology perspective. Ir J Med Sci 180:799-805
    • (2011) Ir J Med Sci , vol.180 , pp. 799-805
    • Bourke, T.1
  • 2
    • 0242522154 scopus 로고    scopus 로고
    • American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
    • 14607462 10.1016/S0735-1097(03)00941-0
    • Maron BJ, McKenna WJ, Danielson GK et al (2003) American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 42:1687-1713
    • (2003) J Am Coll Cardiol , vol.42 , pp. 1687-1713
    • Maron, B.J.1    McKenna, W.J.2    Danielson, G.K.3
  • 3
    • 33751250500 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction
    • 17088454 10.1161/CIRCULATIONAHA.106.644682
    • Maron MS, Olivotto I, Zenovich AG et al (2006) Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232-2239
    • (2006) Circulation , vol.114 , pp. 2232-2239
    • Maron, M.S.1    Olivotto, I.2    Zenovich, A.G.3
  • 4
    • 33845337036 scopus 로고    scopus 로고
    • Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia
    • 17134988 10.1080/14734220600913246 1:CAS:528:DC%2BD2sXotValtg%3D%3D
    • Michael S, Petrocine SV, Qian J et al (2006) Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia. Cerebellum 5:257-267
    • (2006) Cerebellum , vol.5 , pp. 257-267
    • Michael, S.1    Petrocine, S.V.2    Qian, J.3
  • 5
    • 0035138072 scopus 로고    scopus 로고
    • Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits
    • 11175786 10.1038/84818 1:CAS:528:DC%2BD3MXhtFGktbs%3D
    • Puccio H, Simon D, Cossee M et al (2001) Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits. Nat Genet 27:181
    • (2001) Nat Genet , vol.27 , pp. 181
    • Puccio, H.1    Simon, D.2    Cossee, M.3
  • 6
    • 79953753153 scopus 로고    scopus 로고
    • Cardiomyopathy of Friedreich's ataxia: Use of mouse models to understand human disease and guide therapeutic development
    • 21360265 10.1007/s00246-011-9943-6
    • Payne RM, Pride PM, Babbey CM (2011) Cardiomyopathy of Friedreich's ataxia: use of mouse models to understand human disease and guide therapeutic development. Pediatr Cardiol 32:366-378
    • (2011) Pediatr Cardiol , vol.32 , pp. 366-378
    • Payne, R.M.1    Pride, P.M.2    Babbey, C.M.3
  • 7
    • 0033027550 scopus 로고    scopus 로고
    • Marked variation in the cardiomyopathy associated with Friedreich's ataxia
    • 9922348 1:STN:280:DyaK1M7jtVaiug%3D%3D
    • Dutka DP, Donnelly JE, Nihoyannopoulos P et al (1999) Marked variation in the cardiomyopathy associated with Friedreich's ataxia. Heart 81:141-147
    • (1999) Heart , vol.81 , pp. 141-147
    • Dutka, D.P.1    Donnelly, J.E.2    Nihoyannopoulos, P.3
  • 8
    • 79959547500 scopus 로고    scopus 로고
    • Early Changes in left ventricular long-axis function in Friedreich ataxia: Relation with the FXN gene mutation and cardiac structural change
    • 21570254 10.1016/j.echo.2011.04.004
    • Mottram PM, Delatycki MB, Donelan L et al (2011) Early Changes in left ventricular long-axis function in Friedreich ataxia: Relation with the FXN gene mutation and cardiac structural change. J Am Soc Echocardiogr 24:782-789
    • (2011) J Am Soc Echocardiogr , vol.24 , pp. 782-789
    • Mottram, P.M.1    Delatycki, M.B.2    Donelan, L.3
  • 9
    • 0032948208 scopus 로고    scopus 로고
    • Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: A multi-institutional experience
    • 10328154 10.1016/S1053-2498(98)00030-8 1:STN:280:DyaK1M3lvVOjtA%3D%3D
    • Shaddy RE, Tani LY, Gidding SS et al (1999) Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. J Heart Lung Transplant 18:269-274
    • (1999) J Heart Lung Transplant , vol.18 , pp. 269-274
    • Shaddy, R.E.1    Tani, L.Y.2    Gidding, S.S.3
  • 10
    • 34548570632 scopus 로고    scopus 로고
    • Carvedilol for children and adolescents with heart failure: A randomized controlled trial
    • 17848651 10.1001/jama.298.10.1171
    • Shaddy RE, Boucek MM, Hsu DT et al (2007) Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 298:1171-1179
    • (2007) JAMA , vol.298 , pp. 1171-1179
    • Shaddy, R.E.1    Boucek, M.M.2    Hsu, D.T.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.